News Stocks 

Republican candidate for Georgia governor holds bump stock giveaway

“A Republican candidate for Georgia governor is holding a bump stock giveaway to underscore his opposition to a proposed ban in response to the Las Vegas massacre” writes Caitlin Yilek for washingtonexaminer.com. Republican senators requested the Bureau of Alcohol, Tobacco, Firearms, and Explosives review the legality of bump stocks.Senate Democrats introduced legislation to ban bump stocks in early October after the Las Vegas gunman used the device to increase the rate of his shots on concertgoers.Michael Williams called the opposition to bump stocks — an attachment that enables a semi-automatic…

Read More
Markets News Stocks 

There’s an obscure company that’s ground zero for one of the biggest debates in the stock market

“Credit Suisse analyst Victor Lin is also skeptical of the argument that passive ownership is depriving the stock market of actionable opportunities” writes Joe Ciolli for businessinsider.com. You may not have heard of Meredith Corporation, but it’s shareholder list highlights a tug-of-war in the stock market.While it’s difficult to tell which side will ultimately prove to be right, many point toward a future stock market downturn as a potential catalyzing event.In fact, Meredith has the second-biggest chunk of passive ownership out of all US companies, Credit Suisse finds.Either way, the…

Read More
News Stocks 

Goldman earnings breeze past expectations on trading beat

“After rising during the premarket, shares fell at the market open and were last down about 1.5 percent” writes unknown author for cnbc.com. Also, investment banking revenue of $1.8 billion beat estimates of $1.63 billion, though equities trading revenue fell short of the mark at $1.67 billion against forecasts of $1.77 billion.Fixed income trading revenue was $1.45 billion, against the $1.38 billion projected by FactSet.Traders initially reacted positively to the results, sending shares up as much as 1.4 percent in premarket trading. Source: cnbc.com Share This:

Read More
News Stocks 

Analyst says ‘nobody can compete’ with Tesla in China

“Piper Jaffray reiterated its overweight rating on Tesla shares, saying the company’s electric car quality is far ahead of its peers in China” writes Wang Zhao for cnbc.com. The analyst said China will start an electric vehicle quota system in 2019.Potter reaffirmed his $386 price target on Tesla shares, representing 10 percent upside to Monday’s close. Source: cnbc.com Share This:

Read More
News Stocks 

Stocks making the biggest moves premarket: UNH, MS, JNJ, HOG, CMA, NFLX & more

“The company’s revenue beat forecasts as well, but its profits were down more than 40 percent from a year earlier” writes Michael Nagle for cnbc.com. Sonic – Sonic reported adjusted quarterly profit of 45 cents per share, beating estimates by two cents a share.Morgan Stanley – The investment firm came in 12 cents a share above estimates, with quarterly profit of 93 cents per share.Johnson & Johnson – The medical products and drugmaker reported adjusted quarterly profit of $1.90 per share, 10 cents a share above estimates.Netflix – Netflix posted…

Read More
News Stocks 

Goldman Sachs stock jumps as earnings crush estimates

“Goldman said it had third-quarter net revenue of $8.3 billion, or per-share earnings of $5.02, up from $8.2 billion and $4.88, in the year-ago quarter” writes Andrea Riquier for marketwatch.com. GS, +1.63% jumped more than 1 percent in pre-market trading after the bank reported third-quarter results that handily beat market expectations.But revenues from trading of fixed income, currencies and commodities sank 26% for the year.Investment banking revenue was 17% higher than in the third quarter of 2016, the bank said. Source: marketwatch.com Share This:

Read More
News Stocks 

Impax Laboratories and Amneal Pharmaceuticals to merge, creating the 5th-largest U.S. generics business

“IPXL, -4.09% and privately-held Amneal Pharmaceuticals LLC announced Tuesday an agreement to merge in a all-stock deal, forming a new publicly traded company named Amneal Pharmaceuticals Inc” writes Reporter Editor for marketwatch.com. Impax shareholders will own 25% of the new company’s shares and Amneal Holdings member will own 75%.In connection with the deal, Amneal Holdings member have entered into private-placement agreements with TPG and Fidelity management & Research Co. to sell 46.8 million unregistered common shares at $18.25 a share. Impax’s stock, which is currently halted for news, had run…

Read More
News Reviews Stocks 

Stocks Daily Review October 17, 2017

Stocks Daily Review for October 17, 2017 Political Worries Undermining Euro, Spanish Stocks The Euro is facing downward pressure in Europe Monday as political concerns in Spain, Austria and Germany combine to weaken it.   Asian Shares Rise As Commodities Ride High Asian stocks ended broadly higher on Monday as commodity prices advanced, Chinese inflation data for September met expectations and finance ministers from around the world expressed their desire for lower interest rates at a weekend meeting of the International Monetary Fund.   European Shares Set To Follow Asian…

Read More
News Stocks 

Why investors in Europe should be cautious on the upcoming earnings season

“However, some are worried that such interest in European equities has been disproportionately boosted by earnings forecasts that were too positive” writes European Equity Strategy for cnbc.com. The dissipation of political risks along with strong growth figures and a pickup in inflation have boosted investors’ interest in European stocks — the Euro Stoxx 600 index is up by 7 percent year-to-date.With another earnings season in Europe about to kick off, one equity analyst is concerned that European firms won’t deliver as much return as was expected at the start of…

Read More